Items where authors include "Adams, R"
Up a levelArticle
Gao, C, Peters, M, Kurver, P et al. (203 more authors) (2022) Nomogram predicting the probability of spontaneous stone passage in patients presenting with acute ureteric colic. BJU International, 130 (6). pp. 823-831. ISSN 1464-4096
Henderson, RH, French, D, McFerran, E et al. (10 more authors) (2022) Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. Journal of Cancer Policy, 33. 100342. ISSN 2213-5383
Brown, LC, Graham, J, Fisher, D et al. (15 more authors) (2022) Experiences of running a stratified medicine adaptive platform trial: Challenges and lessons learned from 10 years of the FOCUS4 trial in metastatic colorectal cancer. Clinical Trials, 19 (2). pp. 146-157. ISSN 1740-7745
Richman, SD orcid.org/0000-0003-3993-5041, Hemmings, G, Roberts, H et al. (12 more authors) (2022) FOCUS4 biomarker laboratories: from the benefits to the practical and logistical issues faced during 6 years of centralised testing. Journal of Clinical Pathology. ISSN 0021-9746
Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736
Hoorn, ST, Sommeijer, DW, Elliot, F et al. (12 more authors) (2021) Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone. British Journal of Cancer. ISSN 0007-0920
Yin, J, Cohen, R, Jin, Z et al. (23 more authors) (2021) Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer. Journal of the National Cancer Institute. ISSN 0027-8874
Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736
Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736
Hanna, CR, Slevin, F orcid.org/0000-0002-7176-904X, Appelt, A orcid.org/0000-0003-2792-9218 et al. (17 more authors) (2021) Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clinical Oncology, 33 (4). pp. 214-223. ISSN 0936-6555
O’Cathail, SM, Davis, S, Holmes, J et al. (8 more authors) (2020) A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR). Radiation Oncology, 15 (1). 151. ISSN 1748-717X
Glynne-Jones, R, Meadows, HM, Lopes, A et al. (3 more authors) (2020) Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs. Annals of Oncology, 31 (11). pp. 1587-1588. ISSN 0923-7534
Glynne-Jones, R, Meadows, HM, Lopes, A et al. (4 more authors) (2020) Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus. Results of a post-hoc analysis from the randomized phase III ACT II trial. Annals of Oncology, 31 (10). pp. 1376-1385. ISSN 0923-7534
Gilbert, A, Drinkwater, K, McParland, L et al. (7 more authors) (2020) UK national cohort of anal cancer treated with intensity-modulated radiotherapy: One-year oncological and patient-reported outcomes. European Journal of Cancer, 128. pp. 7-16. ISSN 0959-8049
Keane, C, Fearnhead, NS, Bordeianou, L et al. (194 more authors) (2020) International consensus definition of low anterior resection syndrome. Colorectal Disease, 22 (3). pp. 331-341. ISSN 1462-8910
Shakir, R, Adams, R, Cooper, R et al. (10 more authors) (2020) Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics, 106 (2). pp. 329-339. ISSN 0360-3016
Fish, R, Sanders, C, Adams, R et al. (8 more authors) (2018) A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus. Lancet Gastroenterology and Hepatology, 3 (12). pp. 865-873. ISSN 2468-1253
Cross, W, Kovac, M, Mustonen, V et al. (53 more authors) (2018) The evolutionary landscape of colorectal tumorigenesis. Nature Ecology & Evolution, 2 (10). pp. 1661-1672. ISSN 2397-334X
Gollins, S, West, N orcid.org/0000-0002-0346-6709, Sebag-Montefiore, D orcid.org/0000-0002-5978-9259 et al. (11 more authors) (2018) A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British Journal of Cancer, 119 (6). pp. 697-706. ISSN 0007-0920
Jones, CM, Adams, R, Downing, A orcid.org/0000-0002-0335-7801 et al. (6 more authors) (2018) Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort. International Journal of Radiation Oncology*Biology*Physics, 101 (5). pp. 1202-1211. ISSN 0360-3016
Alderdice, M, Richman, SD orcid.org/0000-0003-3993-5041, Gollins, S et al. (12 more authors) (2018) Prospective patient stratification into robust cancer‐cell intrinsic subtypes from colorectal cancer biopsies. Journal of Pathology, 245 (1). pp. 19-28. ISSN 0022-3417
Adams, R, Brown, E, Brown, L et al. (14 more authors) (2018) Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2–3 randomised trial. Lancet Gastroenterology and Hepatology, 3 (3). pp. 162-171. ISSN 2468-1253
Sjoquist, KM, Renfro, LA, Simes, RJ et al. (31 more authors) (2017) Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. Journal of the National Cancer Institute, 10 (6). djx253. ISSN 0027-8874
Battersby, NJ, Dattani, M, Rao, S et al. (17 more authors) (2017) A Rectal Cancer Feasibility Study with an Embedded Phase III Trial Design Assessing Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker to Stratify Management by Good And Poor Response to Chemoradiotherapy (TRIGGER): study protocol for a randomized controlled trial. Trials, 18. p. 394. ISSN 1745-6215
Muirhead, R, Drinkwater, K, O'Cathail, SM et al. (6 more authors) (2017) Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015. Clinical Oncology, 29 (3). pp. 188-197. ISSN 0936-6555
Seligmann, JF, Fisher, D, Smith, CG et al. (9 more authors) (2017) Investigating the poor outcomes of BRAF - mutant advanced colorectal cancer: Analysis from 2530 patients in randomised clinical trials. Annals of Oncology, 28 (3). pp. 562-568. ISSN 0923-7534
Salem, ME, Yin, J, Renfro, LA et al. (15 more authors) (2017) Rectal versus left-sided colon cancers: Clinicopathological differences observed in a pooled analysis of 4,182 patients enrolled to 8 clinical trials from the ARCAD database. Journal of Clinical Oncology, 35 (Supplement 4). p. 675. ISSN 0732-183X
Morris, EJA, Finan, PJ, Spencer, K et al. (7 more authors) (2016) Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clinical Oncology, 28 (8). pp. 522-531. ISSN 0936-6555
Richman, SD, Adams, R, Quirke, P et al. (10 more authors) (2016) Pre-trial inter-laboratory analytical validation of the FOCUS4 personalised therapy trial. Journal of Clinical Pathology, 69 (1). pp. 35-41. ISSN 0021-9746
Morris, E, Finan, P, Thomas, J et al. (4 more authors) (2015) Using the National Radiotherapy Dataset within the National Cancer Data Repository to investigate patterns of use of radiotherapy in the management of surgically treated rectal cancer across the English NHS. European Journal of Cancer Care, 24 (S1). pp. 20-21. ISSN 0961-5423
Barbieri, M., Weatherly, Helen Louise Ann orcid.org/0000-0002-9117-6452, Ara, Roberta et al. (8 more authors) (2014) What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Applied Health Economics and Health Policy. Applied Health Economics and Health Policy. 497–510. ISSN 1175-5652
Conference or Workshop Item
Adams, R, Fisher, D, Graham, J et al. (13 more authors) (2021) Oral maintenance capecitabine versus active monitoring for patients with metastatic colorectal cancer (mCRC) who are stable or responding after 16 weeks of first-line treatment: Results from the randomized FOCUS4-N trial. In: 2021 ASCO Annual Meeting I, 04-08 Jun 2021, Online.
Yin, J, Cohen, R, Jin, Z et al. (16 more authors) (2020) Prognostic and predictive impact of primary tumor sidedness in first-line trials for advanced colorectal cancer: An analysis of 7,828 patients in the ARCAD database. In: 2020 Gastrointestinal Cancers Symposium, 23-25 Jan 2020, San Francisco, California.
Proceedings Paper
Williams, C, Emmerson, J, Beggs, AD et al. (12 more authors) (2022) A biomarker enrichment trial of anti-EGFR agents in right primary tumor location (rPTL), RAS wild-type (RAS-wt) advanced colorectal cancer (aCRC): ARIEL (ISRCTN11061442). In: Journal of Clinical Oncology. 2022 ASCO Annual Meeting, 03-07 Jun 2022, Online & Chicago, IL, USA. American Society of Clinical Oncology .
Shakir, R, Adams, R, Cooper, R et al. (10 more authors) (2019) P-159: Patterns and predictors of relapse following radical chemoradiotherapy delivered using intensity-modulated radiotherapy with a simultaneous integrated boost in anal squamous cell carcinoma. In: Annals of Oncology. ESMO 21st World Congress on Gastrointestinal Cancer 2019, 03-06 Jul 2019, Barcelona, Spain. Oxford University Press .
Robinson, M, Christophides, D, Abbott, N et al. (7 more authors) (2017) A Novel Pretrial Contouring Exercise for the UK led PersonaLising Anal cancer radioTherapy dOse (PLATO) Trial. In: Proceedings of the American Society for Radiation Oncology. ASTRO's 59th Annual Meeting, 24-27 Sep 2017, San Diego Convention Center, San Diego California. Elsevier , E181-E182.
Richman, SD orcid.org/0000-0003-3993-5041, Adams, R, Brown, E et al. (14 more authors) (2017) FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, bRAF and PIK3CA. In: Journal of Pathology. Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 Jun 2017, Belfast, Northern Ireland, UK. Wiley , S13-S13.
Sebag-Montefiore, D, Adams, R, Bell, S et al. (17 more authors) (2016) The Development of an Umbrella Trial (PLATO) to Address Radiation Therapy Dose Questions in the Locoregional Management of Squamous Cell Carcinoma of the Anus. In: Proceedings of the American Society for Radiation Oncology. 58th Annual Meeting of the American Society for Radiation Oncology, 25-28 Sep 2016. Elsevier , E164-E165.
Morris, EJA, Finan, PJ, Quirke, P et al. (5 more authors) (2015) Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the english NHS. In: Gut. 2nd Digestive Disorders Federation Conference, 22-25 Jun 2015, London, UK. BMJ Publishing Group , A148-A148.
Gollins, S, Sebag-Montefiore, D, Adams, R et al. (9 more authors) (2015) A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171). In: Journal of Clinical Oncology. 2015 ASCO Annual Meeting, 29 May - 02 Jun 2015, Chicago, IL, USA. American Society of Clinical Oncology .